The Bongaerts clinical screening score (CSS) for diabetes related peripheral neuropathy (DPN)was developed in an attempt to improve screening for DPN. This study aimed to test the\ud predictive validity of the Bongaerts models for detecting DPN in a cohort with type 1 and type 2 diabetes
Background and Purpose: Diabetic peripheral neuropathy (DPN) leads to ulceration, noninvasive amputa...
AIMS: To provide one of the diagnostic categories for distal diabetic polyneuro-pathy,several sympto...
Diabetic peripheral neuropathy (DPN) is the most common complication of both type 1 and 2 diabetes. ...
The Bongaerts clinical screening score (CSS) for diabetes related peripheral neuropathy (DPN)was dev...
AIMS: Since screening for distal sensorimotor polyneuropathy (DSPN) in individuals with diabetes is ...
Background Diabetic peripheral neuropathy (DPN) is one of the most serious complications of type 2 d...
Background: Peripheral nerve damage is a common complication of diabetes mellitus and often presents...
The early stages of diabetic peripheral neuropathy (DPN) are symptomless. A reliable dependable and ...
Background/aim Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mell...
Background: Almost half of Diabetic Peripheral Neuropathies (DPNs) are symptom-free. Methods includi...
The high prevalence of Type 2 Diabetes (T2D) in the United Arab Emirates makes it imperative to scre...
Background: Neuropathy is a major cause of morbidity and mortality in type 1 and 2 diabetes worldwid...
Background: Presence of symptoms of peripheral neuropathy (PN) in diabetes mellitus (DM) does not in...
Aims The Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal symmetrical periph...
Background: Diabetes peripheral neuropathy commonly occurs among people with diabetes, accounting fo...
Background and Purpose: Diabetic peripheral neuropathy (DPN) leads to ulceration, noninvasive amputa...
AIMS: To provide one of the diagnostic categories for distal diabetic polyneuro-pathy,several sympto...
Diabetic peripheral neuropathy (DPN) is the most common complication of both type 1 and 2 diabetes. ...
The Bongaerts clinical screening score (CSS) for diabetes related peripheral neuropathy (DPN)was dev...
AIMS: Since screening for distal sensorimotor polyneuropathy (DSPN) in individuals with diabetes is ...
Background Diabetic peripheral neuropathy (DPN) is one of the most serious complications of type 2 d...
Background: Peripheral nerve damage is a common complication of diabetes mellitus and often presents...
The early stages of diabetic peripheral neuropathy (DPN) are symptomless. A reliable dependable and ...
Background/aim Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mell...
Background: Almost half of Diabetic Peripheral Neuropathies (DPNs) are symptom-free. Methods includi...
The high prevalence of Type 2 Diabetes (T2D) in the United Arab Emirates makes it imperative to scre...
Background: Neuropathy is a major cause of morbidity and mortality in type 1 and 2 diabetes worldwid...
Background: Presence of symptoms of peripheral neuropathy (PN) in diabetes mellitus (DM) does not in...
Aims The Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal symmetrical periph...
Background: Diabetes peripheral neuropathy commonly occurs among people with diabetes, accounting fo...
Background and Purpose: Diabetic peripheral neuropathy (DPN) leads to ulceration, noninvasive amputa...
AIMS: To provide one of the diagnostic categories for distal diabetic polyneuro-pathy,several sympto...
Diabetic peripheral neuropathy (DPN) is the most common complication of both type 1 and 2 diabetes. ...